{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:57:34Z","timestamp":1781207854617,"version":"3.54.1"},"reference-count":49,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"National Institute of Health","award":["1F31AI161946-01"],"award-info":[{"award-number":["1F31AI161946-01"]}]},{"name":"National Institute of Health","award":["R01AI136963"],"award-info":[{"award-number":["R01AI136963"]}]},{"name":"National Institute of Health","award":["R01AI173406"],"award-info":[{"award-number":["R01AI173406"]}]},{"name":"National Institute of Health","award":["R01DK114456"],"award-info":[{"award-number":["R01DK114456"]}]},{"name":"National Institute of Health","award":["T32AI138945"],"award-info":[{"award-number":["T32AI138945"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Type 1 diabetes (T1D) is an autoimmune disease characterized by progressive stages culminating in T-cell\u2013mediated destruction of the \u03b2-cells at the islets of Langerhans. The immune mechanisms that initiate T1D are not fully resolved but likely involve an interaction between proinflammatory antigen-presenting cells (APCs) and autoreactive T cells that initiate immune infiltration and activation. Previous studies have tested the use of tolerogenic APCs in adult female NOD mice to delay or prevent T1D with only slight to intermediate success. Moreover, immune infiltration begins as early as age 4 weeks; therefore, targeting autoreactive T cells with tolerogenic APCs in adult mice may not impact later stages of diabetes. Thus, we hypothesize that the transfer of tolerogenic APCs at the neonatal stage prior to priming and immune infiltration will result in effective protection from autoimmunity. Our studies demonstrate that immature APCs travel to the pancreatic draining lymph nodes, alter the cytokine milieu in young mice, divert autoreactive CD4+ T cells to anergy, and drastically decrease proliferation and function of cytotoxic lymphocytes in adult prediabetic mice, leading to a significant reduction in the incidence of T1D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>Neonatal transfer of immature dendritic cell\u2013enriched Flt3L splenocytes significantly reduces the incidence of type 1 diabetes in female NOD mice. Early time points are associated with accumulation of anergic T cells. In adult mice, there is a reduction in CD4 T helper 1 cells and reduced proliferation and perforin of CD8 T cells. Our work demonstrates how targeting the neonatal window of tolerance alters autoimmunity outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-0055","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:59:59Z","timestamp":1762448399000},"page":"133-143","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["Flt3L-Derived Antigen-Presenting Cell Transfer in Neonatal NOD Mice Reduces the Incidence of Type 1 Diabetes"],"prefix":"10.2337","volume":"75","author":[{"given":"Stephanie","family":"Orozco","sequence":"first","affiliation":[{"name":"Division of Microbiology and Immunology, Department of Pathology, University of Utah 1 , Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Aljobaily","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Immunology, Department of Pathology, University of Utah 1 , Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley M.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Immunology, Department of Pathology, University of Utah 1 , Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina A.","family":"Oceguera","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Immunology, Department of Pathology, University of Utah 1 , Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lee","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine 2 , Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6415-7731","authenticated-orcid":false,"given":"Maria","family":"Bettini","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Immunology, Department of Pathology, University of Utah 1 , Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5596-186X","authenticated-orcid":false,"given":"Matthew L.","family":"Bettini","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Immunology, Department of Pathology, University of Utah 1 , Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"2026061115272780100_B1","doi-asserted-by":"crossref","first-page":"101565","DOI":"10.1016\/j.molmet.2022.101565","article-title":"Beta cell and immune cell interactions in autoimmune type 1 diabetes: how they meet and talk to each other","volume":"64","author":"Scherm","year":"2022","journal-title":"Mol Metab"},{"key":"2026061115272780100_B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/9780470942390.mo120154","article-title":"Genetic and pharmacologic models for type 1 diabetes","volume":"3","author":"Leiter","year":"2013","journal-title":"Curr Protoc Mouse Biol"},{"key":"2026061115272780100_B3","doi-asserted-by":"crossref","first-page":"4106518","DOI":"10.1155\/2020\/4106518","article-title":"Two to tango: dialogue between adaptive and innate immunity in type 1 diabetes","volume":"2020","author":"Sun","year":"2020","journal-title":"J Diabetes Res"},{"key":"2026061115272780100_B4","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2353\/ajpath.2006.060539","article-title":"In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model","volume":"169","author":"Calderon","year":"2006","journal-title":"Am J Pathol"},{"key":"2026061115272780100_B5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.1001398","article-title":"Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes","volume":"185","author":"Katz","year":"2010","journal-title":"J Immunol"},{"key":"2026061115272780100_B6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1074-7613(02)00365-5","article-title":"In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens","volume":"17","author":"Jung","year":"2002","journal-title":"Immunity"},{"key":"2026061115272780100_B7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1084\/jem.189.2.331","article-title":"Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes","volume":"189","author":"H\u00f6glund","year":"1999","journal-title":"J Exp Med"},{"key":"2026061115272780100_B8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1084\/jem.20011353","article-title":"Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice","volume":"196","author":"Gagnerault","year":"2002","journal-title":"J Exp Med"},{"key":"2026061115272780100_B9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.immuni.2024.07.024","article-title":"CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes","volume":"57","author":"Mitchell","year":"2024","journal-title":"Immunity"},{"key":"2026061115272780100_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5463879","article-title":"Immature dendritic cell therapy confers durable immune modulation in an antigen-dependent and antigen-independent manner in nonobese diabetic mice","volume":"2018","author":"Lo","year":"2018","journal-title":"J Immunol Res"},{"key":"2026061115272780100_B11","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2337\/diabetes.53.8.1995","article-title":"Flt3-ligand treatment prevents diabetes in NOD mice","volume":"53","author":"Chilton","year":"2004","journal-title":"Diabetes"},{"key":"2026061115272780100_B12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaut.2009.11.010","article-title":"Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment","volume":"34","author":"Van Belle","year":"2010","journal-title":"J Autoimmun"},{"key":"2026061115272780100_B13","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.2337\/diabetes.52.8.1976","article-title":"Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity","volume":"52","author":"Ma","year":"2003","journal-title":"Diabetes"},{"key":"2026061115272780100_B14","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2337\/diabetes.48.12.2300","article-title":"Immunotherapy of NOD mice with bone marrow-derived dendritic cells","volume":"48","author":"Feili-Hariri","year":"1999","journal-title":"Diabetes"},{"key":"2026061115272780100_B15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/intimm\/dxh210","article-title":"Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development","volume":"17","author":"O\u2019Keeffe","year":"2005","journal-title":"Int Immunol"},{"key":"2026061115272780100_B16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clim.2007.03.002","article-title":"Decreased blood dendritic cell counts in type 1 diabetic children","volume":"123","author":"Vuckovic","year":"2007","journal-title":"Clin Immunol"},{"key":"2026061115272780100_B17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2249.2003.02308.x","article-title":"Passive transfer of Flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice","volume":"134","author":"Morin","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2026061115272780100_B18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI115946","article-title":"Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer","volume":"90","author":"Clare-Salzler","year":"1992","journal-title":"J Clin Invest"},{"key":"2026061115272780100_B19","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1084\/jem.20090300","article-title":"Neonatal tolerance revisited: a perinatal window for Aire control of autoimmunity","volume":"206","author":"Guerau-de-Arellano","year":"2009","journal-title":"J Exp Med"},{"key":"2026061115272780100_B20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.180.3.995","article-title":"Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process","volume":"180","author":"Yang","year":"1994","journal-title":"J Exp Med"},{"key":"2026061115272780100_B21","doi-asserted-by":"crossref","first-page":"15995","DOI":"10.1073\/pnas.0508122102","article-title":"The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation","volume":"102","author":"Lee","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061115272780100_B22","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1073\/pnas.172382999","article-title":"Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice","volume":"99","author":"Wu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061115272780100_B23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1084\/jem.191.2.225","article-title":"Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells","volume":"191","author":"Green","year":"2000","journal-title":"J Exp Med"},{"key":"2026061115272780100_B24","doi-asserted-by":"crossref","first-page":"585880","DOI":"10.3389\/fimmu.2020.585880","article-title":"Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects","volume":"11","author":"Gough","year":"2020","journal-title":"Front Immunol"},{"key":"2026061115272780100_B25","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/eji.201142374","article-title":"IFN-\u03b3 receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells","volume":"42","author":"Yi","year":"2012","journal-title":"Eur J Immunol"},{"key":"2026061115272780100_B26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db16-0846","article-title":"Interferon-\u03b3 limits diabetogenic CD8+ T-cell effector responses in type 1 diabetes","volume":"66","author":"Driver","year":"2017","journal-title":"Diabetes"},{"key":"2026061115272780100_B27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/intimm\/dxp097","article-title":"Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development","volume":"21","author":"Mori","year":"2009","journal-title":"Int Immunol"},{"key":"2026061115272780100_B28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2249.1999.00947.x","article-title":"Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-\u03b3) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice","volume":"117","author":"Shinomiya Akbar","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2026061115272780100_B29","doi-asserted-by":"crossref","first-page":"100244","DOI":"10.1016\/j.xpro.2020.100244","article-title":"Evaluating cytokine production by flow cytometry using brefeldin A in mice","volume":"2","author":"Kovacs","year":"2021","journal-title":"STAR Protoc"},{"key":"2026061115272780100_B30","first-page":"3239","article-title":"Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand","volume":"60","author":"Mach","year":"2000","journal-title":"Cancer Res"},{"key":"2026061115272780100_B31","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.4049\/jimmunol.174.7.4070","article-title":"The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed","volume":"174","author":"Riol-Blanco","year":"2005","journal-title":"J Immunol"},{"key":"2026061115272780100_B32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fimmu.2017.00327","article-title":"The role of dendritic cell maturation in the induction of insulin-dependent diabetes mellitus","volume":"8","author":"Mbongue","year":"2017","journal-title":"Front Immunol"},{"key":"2026061115272780100_B33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ni.3331","article-title":"CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors","volume":"17","author":"Kalekar","year":"2016","journal-title":"Nat Immunol"},{"key":"2026061115272780100_B34","doi-asserted-by":"crossref","first-page":"108748","DOI":"10.1016\/j.celrep.2021.108748","article-title":"Dynamic adoption of anergy by antigen-exhausted CD4+ T cells","volume":"34","author":"Trefzer","year":"2021","journal-title":"Cell Rep"},{"key":"2026061115272780100_B35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/intimm\/dxh207","article-title":"CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production","volume":"17","author":"Barthlott","year":"2005","journal-title":"Int Immunol"},{"key":"2026061115272780100_B36","doi-asserted-by":"crossref","first-page":"704578","DOI":"10.3389\/fimmu.2021.704578","article-title":"Conversion of anergic T cells into Foxp3- IL-10+ regulatory T cells by a second antigen stimulus in vivo","volume":"12","author":"Thomann","year":"2021","journal-title":"Front Immunol"},{"key":"2026061115272780100_B37","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1084\/jem.20120342","article-title":"Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo","volume":"209","author":"Zheng","year":"2012","journal-title":"J Exp Med"},{"key":"2026061115272780100_B38","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41467-021-23044-9","article-title":"Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance","volume":"12","author":"Wagle","year":"2021","journal-title":"Nat Commun"},{"key":"2026061115272780100_B39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.0105-2896.2006.00422.x","article-title":"Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity","volume":"212","author":"Yamazaki","year":"2006","journal-title":"Immunol Rev"},{"key":"2026061115272780100_B40","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1073\/pnas.1834400100","article-title":"CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes","volume":"100","author":"Green","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026061115272780100_B41","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3389\/fimmu.2017.02001","article-title":"CD4+ T helper cells play a key role in maintaining diabetogenic CD8+ T cell function in the pancreas","volume":"8","author":"Espinosa-Carrasco","year":"2017","journal-title":"Front Immunol"},{"key":"2026061115272780100_B42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/dxn007","article-title":"CTLA-4\u00b7Ig converts naive CD4+CD25\u2212 T cells into CD4+CD25+ regulatory T cells","volume":"20","author":"Razmara","year":"2008","journal-title":"Int Immunol"},{"key":"2026061115272780100_B43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat Immunol"},{"key":"2026061115272780100_B44","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.ajpath.2011.02.015","article-title":"Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes","volume":"178","author":"Graham","year":"2011","journal-title":"Am J Pathol"},{"key":"2026061115272780100_B45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/icb.2015.89","article-title":"Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes","volume":"94","author":"Trivedi","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"2026061115272780100_B46","doi-asserted-by":"crossref","first-page":"108893","DOI":"10.1016\/j.clim.2021.108893","article-title":"Fulminant type 1 diabetes patients display high frequencies of IGRP-specific type 1 CD8+ T cells","volume":"233","author":"Chujo","year":"2021","journal-title":"Clin Immunol"},{"key":"2026061115272780100_B47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.1203288","article-title":"Neonatal follicular Th cell responses are impaired and modulated by IL-4","volume":"191","author":"Debock","year":"2013","journal-title":"J Immunol"},{"key":"2026061115272780100_B48","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.immuni.2015.10.016","article-title":"A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes","volume":"43","author":"Scharschmidt","year":"2015","journal-title":"Immunity"},{"key":"2026061115272780100_B49","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/imm.12343","article-title":"\u2018Default\u2019 generated neonatal regulatory T cells are hypomethylated at conserved non-coding sequence 2 and promote long-term cardiac allograft survival","volume":"143","author":"Cheng","year":"2014","journal-title":"Immunology"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/1\/133\/845533\/db250055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/1\/133\/845533\/db250055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:27:38Z","timestamp":1781206058000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/1\/133\/163757\/Flt3L-Derived-Antigen-Presenting-Cell-Transfer-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,6]]},"published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-0055","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}